Venture Capital

A Texas battery plant is online in record time thanks to a Chinese robotics firm. Discover the 'factory in a box' strategy transforming industrial deployment.

Behind the rise of regional streaming giant Chaupal lies a massive tech overhaul. Discover how a B2B partnership enabled a seamless 10M user migration.

A novel drug for heart failure shows promising safety and efficacy data, potentially disrupting a multi-billion dollar market and validating a key investor's strategy.

Bill Ackman's fund is buying back its own shares at a deep discount. We explore the innovative financial strategy and its impact on shareholder value.

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

The junior explorer is terminating its NWA project option to double down on promising uranium anomalies in Wyoming and a major conductive corridor in Athabasca.

With a new $730K grant, Sunrise New Energy is tackling silicon-carbon anode challenges to unlock the next generation of high-density batteries.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

Junior miner Walker Lane Resources seeks a strategic partner after permitting woes stalled its 2025 plans. Can it unlock its Nevada gold potential?

An Auckland firm is using Meta Smart Glasses for pest inspections, giving clients an unprecedented look inside their walls and setting a new standard for transparency.

A strategic investment firm's move signals strong confidence in the closing of Avadel's multi-billion dollar deal, spotlighting its blockbuster sleep drug.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

A 1.26% stake in Just Group, held via derivatives by Balyasny, reveals a classic merger arbitrage strategy as Brookfield's £2.4bn acquisition nears.